Lung-Protective Ventilation
LPV strategies minimize VILI by the following
mitigate volutrauma w/a TV 4-8 mL/PBW
mitigate barotrauma w/a PPlat < 30
mitigate atelectrauma w/a driving pressure (PPlat - PEEP) of 5-15
mitigate hyperoxia w/an SpO2 88-96% & paO2 55-90%
mitigate biotrauma w/all of the above
ARDSNet
As late as the 1990s it was common practive to ventilate with TVs of 10-15 mL/kg actual body weight
this changed in 2000 with publication of the ARDSnet ARMA study, which demonstrated a TV of 6 vs 12 mL/kg predicted body weight decreased mortality to 31.0% from 39.8% (p=0.007, NNT 11) and increased ventilator-free days to 12 from 10 (p=0.007)
the protocol used low tidal volumes to minimize volutrauma & higher PEEPs to prevent de-recruitment of alveoli
Ventilator-Induced Lung Injury
VILI refers to acute injury of the small airways & lung parenchyma caused by, exacerbated by, or simply associated with mechanical ventilation; there is specific terminology for the precise mechanism of injury:
volutrauma: alveolar overdistention due to elevated transalveolar pressure; the term "volu" is used because studies reference this injury pattern in the context of high tidal volume ventilation
barotrauma: alveolar rupture due to elevated transalveolar pressure, leading to PTX, pneumomediastinum, pneumoperitoneum, & subcutaneous emphysema
atelectrauma: shear force generated by cyclic alveolar expansion (during inspiration) & collapse (during exhalation) that distends & injures adjacent alveoli & airways
biotrauma: volutrauma- and/or atelectrauma-related release of inflammatory mediators which independently cause further lung injury, which may be related to subsequent development of pulmonary fibrosis
Compliance
compliance is the ratio of between the change in volume to the change in pressure
C = ΔP / ΔV
conceptually, compliance refers stiffness vs floppiness
low compliance: a higher pressure change produces a smaller volume change (i.e., a stiff lung)
high compliance: a lower pressure changes produces a larger volume change (i.e., a floppy lung)
total compliance of the respiratory system (compRS) comes from both chest wall compliance (compCW) & the lungs (compL), which are considered together in a parallel circuit
1 / compRS = 1 / compCW + 1 / compL
therefore, any disease process that affects the lungs (i.e., PNA, atelectasis, pulmonary fibrosis, pulmonary edema, PTX) or chest wall (subcutaneous edema, circumferential burn, elevated intra-abdominal pressure) will affect respiratory system compliance
Tidal Volumes
The major risk factor for VILI is volutrauma
ARDSNet ARMA showed that low TVs based on predicted body weight (PBW) produce a clinically significant mortality reduction
the appropriate TV depends on PBW, where the underlying assumption is that lungs do not change in size despite the patient's adiposity (MDCalc)
males: PBW [kg] = 0.91 × (height [cm] − 152.4) + 50
females: PBW [kg] = 0.91 × (height [cm] − 152.4) + 45.5
in general, the initial TV should be 6-8 mL/kg PBW
if the patient has ARDS, a TV of 4-6 mL/kg PBW is more appropriate
if the patient has obstructive lung disease, a TV of 7-8 is ideal to prevent air trapping
exceeding a TV of 8 mL/kg PBW has been shown to cause VILI
Plateau Pressure
Once the TV is determined, check the distending pressure on the alveoli, known as the plateau pressure (PPlat)
The PPlat is obtained by performing an end-inspiratory pause for 0.5-1.0 seconds
Pausing end-inspiration means flow stops & pressure equilibrates across the large & small airways
PPlat therefore represents the portion of peak inspiratory pressure (PIP) actually applied to the small airways & alveoli
the gradient between PIP & PPlat represents pressure due to airway resistance
the gradient between PPlat & PEEP represents pressure due to respiratory system compliance
ARDSNet set the cap on PPlat at 30 cm because it is assumed to be normal
PPlats generated during PFTs at TLC are about 30-35 (assuming normal compliance)
Collagen fibers comprising the blood gas barrier can withstand a pressure of about 35
The Baby Lung Concept
ARDS is a heterogenous disease (pockets of healthy alveoli & diseased alveoli occupying the same lobes & segments)
as ARDS worsens, fewer healthy alveoli remain to exchange gas
therefore, in ARDS, the reduction in compliance is not like that of pulmonary fibrosis; rather, it is because the functional lungs are much smaller
this healthy lung tissue is what is used during mechanical ventilation & injuring healthy tissue will only worsen things
PBW, unfortunately, does not predict the size of the "baby lung"
in other words, low TVs are not the whole story for LPV
Stress & Strain
Stress applied to the lung refers to the trans-pulmonary pressure that alveoli feel at end-inspiration
Stress is inferred by the driving pressure, calculated by gradient between PPlat & PEEP
Strain is related to the volume change from FRC to the volume at end-inspiration
Strain is conceptually lung "unfolding" where alveoli are not truly balloons and do not inflate uniformly
Strain is literally the force placed on elastic collagen fibers during the volume changes, and it is inferred by the ratio of TV to functional residual capacity (FRC)
FRC is the lung volume at end-expiration (inward pull of the lungs is balanced by outward pull of chest wall)
at FRC, healthy alveoli remain open & participate in gas exchange
most disease states that cause RF are restrictive, thereby reducing FRC
normal FRC is about 35 mL/kg PBW
we can allow TV up to the total lung capacity (TLC)
healthy TLC is about 80 mL/kg PBW
If we allow the TV up to a healthy TLC of 80 mL/kg PBW, from an FRC of 35 mL/kg PBW, then
a healthy TV would be 45 mL/kg PBW
normal strain is therefore TV / FRC = 45 / 35 = 1.3
Stress & strain are related as follows: stress = k × strain
k is lung elastance, which in both healthy & diseased human lung is known to be 13.5 cm H2O / L
If we substitute driving pressure for stress, 1.3 for strain, and 13.5 for k, then we get
driving pressure = 13.5 x 1.3 = 17 cm H2O
no prospective clinical trials have proven that using a driving pressure-governed ventilation strategy reduces mortality
but the theory is that a driving pressure < 17 balances stress & strain
a retrospective review of ARDSNet data demonstrated that a driving pressure > 15 cm H2O was associated with excess mortality
Stress Multipliers
in disease states, open alveoli are often adjacent to flooded and/or collapsed alveoli
walls of the collapsed alveoli tug on those of healthy alveoli
when stress is applied, the effect on the healthy alveoli is therefore multiplied
stress can theoretically be multiplied as much as 4.64 times when healthy alveoli are surrounded by diseased alveoli
i.e., a PPlat of 30 could generate a trans-pulmonary pressure of 140
in practice, the multiplier seems to be closer to 2.0
multipliers are most pronounced in areas of atelectasis
PEEP recruits collapsed lung units & prevents collapsing at end-expiration
adequate PEEP spreads out stress among more lung tissue
this generally requires 5-15 of PEEP
if PEEP is too low you won't reduce atelectrauma
if PEEP is too high, alveoli septae can rupture & cause hemorrhagic pulmonary edema
high PEEP also can compromise RV function
Prone positioning also moderates stress
much of lung collapse in ARDS is from gravitational compression
periodically changing from supine to prone changes the gravitational vector, thereby helping to open collapsed lung units
proning also "homogenizes" intra-thoracic pressure among lung units
when supine, the anterior chest wall moves forward easily during respiration
the ventral lung units therefore get the bulk of ventilation
the dorsal lung units tend to remain collapsed
when placed in the prone position, anterior chest wall excursion is limited
since the posterior wall is constrained by the ribs, spine, & scapulae, the breath delivery is spread more evenly throughout the lungs
Airway pressure release ventilation (APRV) can also mitigate stress
lungs are not uniformly elastic like a rubber band or balloon
lungs are viscoelastic, akin to silly putty or Play-Doh, where a change in pressure will inflate the lungs, but it takes more time for the alveoli to unfold into a fully inflated form
likewise, a sudden drop in airway pressure will lead to alveolar collapse, but over time
APRV capitalizes on this principle by using a prolonged high pressure w/periodic releases to open up & stabilize the lung
release times are short enough to permit expiratory gas flow while not allowing lung units to collapse
these benefits of APRV are not well studied, but in theory are consistent with LPV
Oxygen Toxicity
FiO2 > 60% was described in the 1970s as associated w/lung injury
recall, this this was an era when low (or no) PEEP and TVs of 10-15 mL/kg ABW
in neonates, paO2 > 150 is associated w/retinal hyperplasia & blindness
cerebral & cardiac vasoconstriction have also been described w/hyperoxemia
hyperoxemia is thought to exacerbate normal ROS formation, exceeds natural antioxidant mechanisms, thereby contributing to inflammation
paO2 > 300 is associated w/higher risk of in-hospital mortality in patients w/cardiac arrest & hypoxic-ischemic encephalopathy
routine administration of 8 L/min O2 to patients with STEMI is associated w/a larger infarct size & a higher rate of recurrent MI
targeting a paO2 of 70-100% & SpO2 94-98% reduces mortality compared to goal paO2 up to 150 & goal SpO2 97-100%
targeting goal SpO2 91-96% has no effect on mortality or LOS when compared w/a goal of 91-100%